Today's noteworthy downgrades include: ACADIA (ACAD) downgraded to Neutral from Overweight at Piper Jaffray... ANADIGICS (ANAD) downgraded to Hold from Buy at Lake Street... AVI BioPharma (AVII) downgraded to Neutral from Buy at SunTrust... Alnylam (ALNY) downgraded to Neutral from Overweight at JPMorgan... Alpha & Omega (AOSL) downgraded on weak end markets, negative read throughs at Stifel... Avago (AVGO) downgraded to Hold from Buy at Drexel Hamilton... Broadcom (BRCM) downgraded to Neutral from Outperform at Wedbush... Caladrius (CLBS) downgraded to Speculative Hold from Speculative Buy at Benchmark Co.... Emerge Energy (EMES) downgraded to Neutral at Baird... Fairchild (FCS) downgraded to Hold from Buy at Drexel Hamilton... Fluidigm (FLDM) downgraded to Neutral from Overweight at Piper Jaffray... Goodrich Petroleum (GDP) downgraded to In-Line from Outperform at Imperial Capital... Hi-Crush Partners (HCLP) downgraded to Sector Perform from Outperform at RBC Capital... Iconix Brand (ICON) downgraded to Hold from Buy at Wunderlich... Infineon (IFNNY) downgraded to Hold from Buy at Drexel Hamilton... Intel (INTC) downgraded to Hold from Buy at Drexel Hamilton... MarkWest Energy (MWE) downgraded to Neutral from Outperform at Credit Suisse... Markel (MKL) downgraded to Sector Perform from Outperform at RBC Capital... Merge Healthcare (MRGE) downgraded to Hold from Buy at Topeka... Michael Kors (KORS) downgraded to Underweight from Neutral at Piper Jaffray... Micron (MU) downgraded to Hold from Buy at Drexel Hamilton... Mistras (MG) downgraded to Equal Weight from Overweight at Stephens... NeoPhotonics (NPTN) downgraded to Neutral from Buy at B. Riley... Noodles & Company (NDLS) downgraded to Neutral from Overweight at Piper Jaffray... Ophthotech (OPHT) downgraded to Sell from Neutral at Goldman... PGT, Inc. (PGTI) downgraded to Hold from Buy at Craig-Hallum... PHH Corp. (PHH) downgraded to Market Perform from Outperform at FBR Capital... Penn Virginia (PVA) downgraded to Neutral from Outperform at Credit Suisse... PennyMac Mortgage (PMT) downgraded to Neutral from Buy at Citi... Sally Beauty (SBH) downgraded to Neutral from Buy at B. Riley... Sarepta (SRPT) downgraded to Neutral from Buy at SunTrust... Shutterstock (SSTK) downgraded to Hold from Buy at Jefferies... Sprouts Farmers Markets (SFM) downgraded to Equal Weight from Overweight at Stephens... TCP International (TCPI) downgraded to Hold from Buy at Deutsche Bank... Tangoe (TNGO) downgraded to Hold from Buy at Deutsche Bank... Teradata (TDC) downgraded to Neutral at Susquehanna... Texas Instruments (TXN) downgraded to Hold from Buy at Drexel Hamilton... Ubiquiti Networks (UBNT) downgraded to Underperform from Market Perform at Raymond James... Viacom (VIAB) downgraded to Market Perform from Outperform at Wells Fargo... Walker Innovation (PPRO) downgraded to Neutral from Buy at Ladenburg... Xilinx (XLNX) downgraded to Hold from Buy at Drexel Hamilton.

New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).

ProQR Therapeutics (PRQR) announced the Annual General Meeting, AGM, of Shareholders will take place on Wednesday, May 22, 2024 at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands. As part of the AGM, Martin Maier, PhD, is nominated for appointment as a non-executive Board Member for a period of four years. Dr. Maier is Senior Vice President Research heading the Oncology group at Alnylam Pharmaceuticals (ALNY).

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

The U.S. Department of Defense has awarded Intel Foundry Phase Three of its Rapid Assured Microelectronics Prototypes - Commercial, or RAMP-C, program, the company announced. "The award was announced through the National Security Technology Accelerator's consortium-based Strategic and Spectrum Missions Advanced Resilient Trusted Systems Other Transaction Authority program. The third phase of RAMP-C advances the tape-out and testing of early defense industrial base product prototypes, signifying a critical milestone for the program that highlights the readiness of Intel 18A process technology, intellectual property and ecosystem solutions for high-volume manufacturing. As part of the announcement, RAMP-C customers can begin manufacturing commercial and DIB product prototypes on Intel 18A process technology," Intel stated. Reference Link